Page last updated: 2024-08-21

indazoles and a-1331852

indazoles has been researched along with a-1331852 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basaga, H; Gul, O; Karakas, B; Kutuk, O; Ozmay, Y	1

Other Studies

1 other study(ies) available for indazoles and a-1331852

Article	Year
Distinct apoptotic blocks mediate resistance to panHER inhibitors in HER2+ breast cancer cells. Biochimica et biophysica acta. Molecular cell research, 2018, Volume: 1865, Issue:8 Topics: bcl-X Protein; Benzothiazoles; Biphenyl Compounds; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Isoquinolines; Nitrophenols; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolinones; Quinolines; Receptor, ErbB-2; Sulfonamides	2018

Article

Year

Distinct apoptotic blocks mediate resistance to panHER inhibitors in HER2+ breast cancer cells.

Biochimica et biophysica acta. Molecular cell research, 2018, Volume: 1865, Issue:8

Topics: bcl-X Protein; Benzothiazoles; Biphenyl Compounds; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Isoquinolines; Nitrophenols; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolinones; Quinolines; Receptor, ErbB-2; Sulfonamides

2018